Insights+: COVID-19 Healthcare News Monthly Updates – September 2020

Tuba Khan
September 30, 2020
0

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease
PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date

71. Regeneron’s REGN-COV2 Demonstrate Reduction in Viral Load and Improve Symptoms in Non-Hospitalized Patients with COVID-19

Sept 30, 2020 | Clinical Trial

70. Doctors in Lowell Report Positive Outcomes for Second COVID-19 Patient Treated with Laser Therapy

Sept 29, 2020 | Clinical Trial

69. Moleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New Antimetabolites

Sept 29, 2020 | Clinical Trial

68. Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19

Sept 28, 2020 | Clinical Trial

67. COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan

Sept 28, 2020 | Clinical Trial

63. INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800

Sept 28, 2020 | Regulatory

62. FDA Grants IND Approval for Phase II Clinical Trial Using Stemedica’s itMSC Therapy for COVID-19 Patients

Sept 28, 2020 | Regulatory

61. Preventative Nasal Spray Shown to Reduce Viral Replication by up to 96% in COVID-19 Challenge Study

Sept 28, 2020 | Clinical Trial

60. Parade/Cleveland Clinic ‘Healthy Now’ Survey Reveals Positive Long-term Effects of COVID-19 Pandemic: Embracing Healthy Lifestyle Changes, Valuing Personal Relationships, Finding Meaning, Remaining Hopeful

Sept 25, 2020 | Clinical Trial

59. Novavax Initiates P-III Study of its COVID-19 Vaccine in the UK

Sept 25, 2020 | Clinical Trial

58. JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study

Sept 24, 2020 |

57. Influenza or COVID-19? Reliable diagnosis in 75 minutes with new multiplex assay from Abacus Diagnostica

Sept 23, 2020 | Diagnostic

56. J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

Sept 24, 2020 | Clinical Trial

55. DURECT Corporation Announces First Patient Dosed in Phase 2 Safety and Efficacy Study of DUR-928 in COVID-19 Patients with Acute Liver or Kidney Injury

Sept 23, 2020 | Clinical Trial

54. Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19

Sept 23, 2020 | Collaboration

53. Avigan Shows Promising Results in Treatment of COVID Patients in Japan

Sept 23, 2020 | Clinical Trial

52. FDA Authorizes First Point-of-Care Antibody Test for COVID-19

Sept 23, 2020 | Diagnostic

51. DetectaChem Smartphone-Based COVID-19 Test Advances Through NIH RADx (Rapid Acceleration of Diagnostics) Program

Sept 22, 2020 | DigiHealth

50. FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress

Sept 21, 2020 | Regulatory

49. Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-Go COVID-19 Testing Device

Sept 21, 2020 | Collaboration

48. Roche Reports Results of Actemra in P-III EMPACTA Study in Patients with COVID-19 Associated Pneumonia

Sept 18, 2020 | Clinical Trial

47. Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

Sept 18, 2020 | Diagnostic

46. Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies

Sept 18, 2020 | Collaboration

45. NRL, NCATS Scientists Develop Method to Safely Study COVID-19, Other Contagious Diseases

Sept 18, 2020 | Clinical Trial

44. Beech Tree Labs selects Curavit Clinical Research for fully virtual COVID-19 clinical trial

Sept 18, 2020 | Clinical Trial

43. HSS Funds Innovative Research on COVID-19

Sept 18, 2020 | Grant

42. Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells

Sept 18, 2020 | Clinical Trial

41. Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova

Sept 17, 2020 | Clinical Trial

40. Sorrento to Initiate P-I Study of STI-1499 in COVID-19 Positive Patients

Sept 17, 2020 | Clinical Trial

39. CEBINA Reports Positive Findings on the Potency of Azelastine

Sept 17, 2020 | Clinical Trial

38. Seattle AVM Biotechnology Announces Second IND for AVM0703: Clinical Trial Permitted to Treat COVID-19 and Influenza ARDS with its “supercharged” Version of Dexamethasone

Sept 16, 2020 | Regulatory

37. Eli Lilly Reports POC Data of LY-CoV555 in P-II BLAZE-1 Study for COVID-19 in Outpatient Setting

Sept 16, 2020 | Clinical Trial

36. Citius Files Addendum to Mino-Lok Phase 3 Trial Record Keeping Protocol to Advance Trials with COVID-19 Compliance

Sept 15, 2020 | Clinical Trial

35. FUJIFILM Sonosite and the CHEST Foundation Partner for COVID-19 Research

Sept 15, 2020 | Collaboration

34. BenevolentAI’s Platform-Derived Hypothesis for COVID-19 Treatment Validated in US NIAID Randomised Control Trial

Sept 14, 2020 | Clinical Trial

33. Ampion Phase I COVID-19 Patient Trial Results Featured on FOX News

Sept 14, 2020 | Clinical Trial

32. Biotechnology Leader LuminUltra Submits COVID-19 Clinical Diagnostic Testing Kit for Regulatory Authorization in U.S., Canada

Sept 14, 2020 | Diagnostics

31. Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122

Sept 14, 2020 | Diagnostics

30. RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron’s REGN-COV2 Investigational Antibody Cocktail in the UK

Sept 14, 2020 | Clinical Trial

29. Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial

Sept 14, 2020 | Clinical Trial

28. Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine

Sept 14, 2020 | Collaboration

27. Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient – Discharged Following Five Days of Treatment

Sept 11, 2020 | Regulatory

26. Pfizer and BioNTech to Supply 200M Doses of it COVID-19 Vaccine in the EU

Sept 10, 2020 | Collaboration

25. New Study Published in PLOS Medicine Explores Impact of Race, Age & Comorbidities on COVID-19 Mortality

Sept 10, 2020 | Clinical Trial

24. Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial